Little Green Pharma Denmark ApSAktiv

The company's activities comprise production, import, export and trade of medical cannabis as well as other related activities at the management's discretion. The company's primary activity is cultivation and processing of plant material from cannabis plants approved for medicinal use.

The income statement for the period 01.04.24 - 31.03.25 shows a profit/loss of DKK 32,148,532 against DKK 7,395k for the period 01.04.23 - 31.03.24. The balance sheet shows equity of DKK 104,966,695.Change in accounting policiesThe company has changed its accounting policies in the following areas:The company 's management has decided to present its income statement by nature rather than by function as previously, as management believes that this will provide a fairer presentation. Comparative figures have been restated in accordance with the new accounting policy. The change in accounting policy has no impact on the net profit or loss for the year, equity or balance sheet in totalChange in the composition of activitiesLittle Green Pharma Denmark ApS has completed a merger with Lab Service Denmark ApS with Little Green Pharma Denmark ApS as the surviving company. The merger was completed with accounting effect from 1 April 2024. The company has applied the group method in connection with the merger and has restated the comparative figures in the income statement, balance sheet and notes as if the companies had always been merged.

Uddrag af ledelsesberetningen i den seneste årsrapport.